UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 9, 2004
ROCKWELL MEDICAL TECHNOLOGIES, INC.
-----------------------------------
(Exact name of registrant as specified in its Charter)
Michigan 000-230-661 38-3317208
---------------------------- ----------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
30142 Wixom Road, Michigan 48334
--------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (248) 960-9009
Not applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On December 9, 2004, the board of directors of Rockwell Medical
Technologies, Inc. ("Rockwell"), approved an extension of the Warrant Expiration
Date of all of its publicly traded Common Share Purchase Warrants until the 5:00
p.m. (New York, New York time), January 26, 2006.
There is no material relationship between Rockwell and any of the parties
to the above described amendment other than in respect of the amendment.
A copy of the press release issued by Rockwell announcing extension of the
Warrant Expiration Date is filed herewith as Exhibit 99.1 and is incorporated
herein by reference.
Item 3.03 Material Modification to Rights of Security Holders.
On December 9, 2004, the board of directors of Rockwell, approved an
extension of the Warrant Expiration Date of all of its publicly traded Common
Share Purchase Warrants until the 5:00 p.m. (New York, New York time), January
26, 2006.
A copy of the press release issued by Rockwell announcing extension of the
Warrant Expiration Date is filed herewith as Exhibit 99.1 and is incorporated
herein by reference.
Item 7.01 Regulation FD Disclosure.
On December 9, 2004, the board of directors of Rockwell, approved an
extension of the Warrant Expiration Date of all of its publicly traded Common
Share Purchase Warrants until the 5:00 p.m. (New York, New York time), January
26, 2006.
A copy of the press release issued by Rockwell announcing extension of the
Warrant Expiration Date is filed herewith as Exhibit 99.1 and is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
The following exhibit is filed with this Form 8-K:
Exhibit Description
------- -----------
99.1 Press release, dated December 10, 2004, issued by Rockwell
Medical Technologies, Inc.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROCKWELL MEDICAL TECHNOLOGIES, INC.
Date: December 10, 2004 By: /s/ Robert L. Chioini
---------------------
Robert L. Chioini
President and Chief Executive Officer
3
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Press release, dated December 10, 2004, issued by Rockwell Medical
Technologies, Inc.